Natural Products
| Catalog No. | Information |
| CFN95395 | Platycodin J |
| CFN95394 | 5,6,7,3',4'-Pentamethoxyflavanone 5,6,7,3',4'-pentamethoxyflavanone exhibited anti-proliferative activities. 5,6,7,3',4'-Pentamethoxyflavanone inhibit PCSK9 mRNA expression with IC50 values of 21.4. 5,6,7,3',4'-pentamethoxyflavanone could also significantly inhibit NO production. |
| CFN95393 | Dihydrophaseic acid 4'-O-beta-D-glucopyranoside |
| CFN95392 | 10-O-trans-p-Feruloylscandoside |
| CFN95391 | 10-O-trans-p-coumaroylscandoside 10-O-trans-p-coumaroylscandoside,posseses Antioxidant activities and vasodilator effects. |
| CFN95390 | Tortoside B (Manglieside E) Manglieside E significantly (p<0.05) increased the growth and differentiation of osteoblastic MC3T3-E1 cells. |
| CFN95389 | Lariciresinol 4-O-glucoside |
| CFN95388 | Sativanone Sativanone has anti-inflammatory, anti-aging,anti Hyal-1 and antioxidant properties as well as antibacterial activity against Ralstonia solanacearum. Sativaone inhibits yeast alpha-glucosidase. |
| CFN95387 | 3'-O-Methylviolanone 3'-O-methylviolanone has anti-inflammatory activity . |
| CFN95386 | Mucronulatol Mucronulatol has anticancer,antiangiogenic activity. Mucronulatol exhibits markedly potent inhibition of yeast α-glucosidase. |
| CFN95385 | Violanone Violanone, an isoflavanone compound, can inhibit tubulin polymerization. Violanone also exhibits larvicidal activity against A. aegypti. |
| CFN95384 | 3',8-Dihydroxyvestitol 3',8-Dihydroxyvestitol could serve as antiviral drugs for dengue infection. |
| CFN95383 | Methyl 2-hydroxy-3,4-dimethoxybenzoate |
| CFN95381 | New compound 14 |
| CFN95380 | Theaflavanoside II |
| CFN95379 | Methylpicraquassioside B |
| CFN95378 | Picraquassioside B |
| CFN95377 | Yinxiancaoside C Yinxiancaoside C has antitumor effect. |
| CFN95376 | 5,6,7,3',4',5'-Hexamethoxyflavanone 5,6,7,3',4',5'-hexamethoxyflavone has antiproliferative activity against four human cancer cell lines (Aspc-1, HCT-116, HepG-2 and SUN-5). |
| CFN95375 | 3-O-Methylellagic acid 3'-O-alpha-rhamnopyranoside 3-O-Methylellagic acid 3'-O-α-rhamnopyranoside has antioxidant and antibacterial activity. |
| CFN95374 | New compound 13 |
| CFN95373 | Bocconoline Bocconoline strongly perturbs various cellular components of human olfactory neurosphere-derived (hONS) cell lines. Bocconoline exhibited good inhibitory activity in the leukaemia cell line HEL.Bocconoline has anticancer activity . |
| CFN95372 | Toddalolactone 3'-O-methyl ether (6-(2-Hydroxy-3-methoxy-3-methylbutyl)-5,7-dimethoxycoumarin) |
| CFN95371 | New compound 12 (Rhoifolin analog) |
| CFN95370 | 2,3-Dehydrosilychristin 2,3-Dehydrosilychristin might have a biologically relevant inhibitory effect on ADH and glutamate dehydrogenase.2,3-Dehydrosilychristin is highly protective against copper-induced erythrocyte lysis .2,3-Dehydrosilychristin has antioxidant properties。 |
| CFN95369 | Isosilychristin Isosilychristin is an antioxidant with multidrug resistance modulating activity. Isosilychristin significantly induces ABCA1 protein expression without affecting cell viability.Isosilychristin has anticancer and hepatoprotective activity. |
| CFN95368 | Cuneataside C |
| CFN95367 | Hydroxytyrosol 1-O-glucoside Hydroxytyrosol 1-O-glucoside plays a key role in the tolerance of X. fastidiosa to cv. Hydroxytyrosol 1-O-glucoside has antioxidant activity. |
| CFN95366 | Ternatumoside II Ternatumoside II is a flavonoid glycoside that can be isolated from R. crenulata. Ternatumoside II can stimulate IFN-γ expression. Ternatumoside II has radical-scavenging activities (IC50s: 260.5 μM and 320.2 μM for DPPH and ABTS) |
| CFN95365 | 7-O-(4-beta-D-glucopyranosyloxy-3-methoxybenzoyl)secologanolic acid |
| CFN95364 | Eucomic acid Eucomic acid showed the best inhibitory activity against the P. falciparum 3D7, a well-known chloroquine-sensitive strain. Eucommia acid has antioxidant, anti-aging, antibacterial, and AChE inhibitory activities.Eucommia acid promotes wound healing. |
| CFN95363 | Eschweilenol C Eschweilenol C has antifungal, anti-inflammatory, antioxidant, antidiabetic activity. 4-(alpha-rhamnopyranosyl)ellagic acid is an inhibitor of human recombinant aldose reductase HRAR (IC50 = 4.1 x 10(-8) M). |
| CFN95362 | ZP-amide C |
| CFN95361 | Foliachinenoside C |
| CFN95360 | Apigenin 6,8-di-C-alpha-L-arabinopyranoside Apigenin 6,8-di-C-α-L-arabinopyranoside (Apigenin 6,8-di-C-arabinoside) is a natural C-glycosylflavone compound |
| CFN95359 | Dipsacus saponin X |
| CFN95358 | Acacetin 7-[rhamnosyl-(1->2)-galacturonide] |
| CFN95357 | Kaempferol 3,4'-di-O-glucoside Kaempferol 3,4'-diglucoside causing the blueing effects on anthocyanin |
| CFN95356 | 8-Hydroxypinoresinol-4'-O-beta-D-glucopyranoside |
| CFN95355 | Hederagenin 3-O-(2-O-acetyl-alpha-L-arabinopyranoside) Hederagenin 3-O-(2-O-acetyl-α-L-arabinopyranoside) significantly increased alkaline phosphatase (ALP) activity and the level of protein expression of bone sialoprotein (BSP) and osteocalcin (OC) . |
| CFN95354 | Japondipsaponin E1 |
| CFN95353 | Dipsacussaponin C Dipsacussaponin C potently induces procoagulant activity in platelets and leads to increased thrombus formation. DSC has an antinociceptive effect when it is administered supraspinally and GABAA, NMDA and non-NMDA receptors, but not opioid and GABAB receptors located at the supraspinal level, may be involved in DSC-induced antinociception. Dipsacus saponin C evoked hemolysis directly on the erythrocytes. |
| CFN95352 | Apigenin 7-[rhamnosyl-(1->2)-galacturonide] |
| CFN95351 | New compound 11 |
| CFN95350 | Isospinosin |
| CFN95349 | trans-Psoralenoside Trans-Psoralenoside has hepatoprotective, kidney protection, antiulcer and anticoagulant activities. |
| CFN95348 | Planispine A Planispine A has Anti-inflammatory activity. |
| CFN95347 | Secotubeimoside I Reference standards; tubeimoside I analogue. |
| CFN95346 | Dioscoreside E Dioscoreside E showed cytotoxic activity and Anti-fungal activity against a panel of tumor cell lines. |
| CFN95345 | Dioscoreside C Dioscoreside C showed mild cytotoxicity against the cancer cell lines, A375, L929, and HeLa, in a dose-dependent manner. |
